Authors: Parise CA; Sutter Center for Health Systems Research, Sacramento, California, USA.; Sutter Institute for Medical Research, Sacramento, California, USA., Caggiano V; Sutter Institute for Medical Research, Sacramento, California, USA.

Source: Cancer [Cancer] 2023 Mar 01; Vol. 129 (5), pp. 750-763. Date of Electronic Publication: 2023 Jan 03.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

MeSH Terms: Breast Neoplasms, Male*/ethnology , Breast Neoplasms, Male*/mortality, Female ; Humans ; Male ; Breast Neoplasms ; Comorbidity ; Ethnicity ; Hispanic or Latino ; Minority Groups ; California/epidemiology ; Registries

Authors: Clark NM; Department of Surgery, University of Washington, Seattle, USA., Roberts EA; University of Washington School of Medicine, Seattle, USA., Fedorenko C; Hutchinson Institute for Cancer Outcomes Research Fred Hutchinson Cancer Center, Seattle, USA., Sun Q; Hutchinson Institute for Cancer Outcomes Research Fred Hutchinson Cancer Center, Seattle, USA., Dubard-Gault M; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, USA.; Fred Hutchinson Cancer Center, Seattle, USA., Handford C; Fred Hutchinson Cancer Center, Seattle, USA., Yung R; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA., Cheng HH; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA., Sham JG; Department of Surgery, University of Washington, Seattle, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA., Norquist BM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, USA., Flanagan MR; Department of Surgery, University of Washington, Seattle, USA. mrf22@uw.edu.; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, USA. mrf22@uw.edu.

Source: Annals of surgical oncology [Ann Surg Oncol] 2023 Mar; Vol. 30 (3), pp. 1312-1326. Date of Electronic Publication: 2022 Nov 05.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/genetics , Genetic Testing* , Ovarian Neoplasms*/genetics , Prostatic Neoplasms*/genetics , Pancreatic Neoplasms*/genetics, Female ; Humans ; Male ; Genetic Counseling ; Pancreatic Hormones ; Retrospective Studies ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology

Authors: Ferre R; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Elst J; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Senthilnathan S; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Lagree A; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Tabbarah S; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Lu FI; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Sadeghi-Naini A; Department of Electrical Engineering and Computer Science, York University, Toronto, ON, Canada., Tran WT; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Temerty Centre for AI Research and Education, University of Toronto, ON, Canada., Curpen B; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.

Source: Breast disease [Breast Dis] 2023; Vol. 42 (1), pp. 59-66.

Publication Type: Journal Article

Journal Info: Publisher: IOS Press Country of Publication: Netherlands NLM ID: 8801277 Publication Model: Print Cited Medium: Internet ISSN: 1558-1551 (Electronic) Linking ISSN: 08886008 NLM ISO Abbreviation: Breast Dis Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/diagnostic imaging , Breast Neoplasms*/metabolism , Breast Neoplasms*/pathology , Machine Learning* , Ultrasonography*, Female ; Humans ; Pilot Projects ; Receptor, ErbB-2/metabolism ; Retrospective Studies ; Triple Negative Breast Neoplasms/diagnostic imaging ; Middle Aged

Authors: Chevarin M; Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.; Unité Fonctionnelle Innovation diagnostique dans les maladies rares, laboratoire de génétique chromosomique et moléculaire, Plateau Technique de Biologie, CHU Dijon Bourgogne, Dijon, France., Alcantara D; Human DNA Damage Response Disorders Group, University of Sussex, Genome Damage and Stability Centre, Brighton, United Kingdom., Albuisson J; Service d'Oncogénétique, Centre Georges François Leclerc, Dijon, France.; Département de biologie et pathologie des tumeurs, Centre Georges François Leclerc, Dijon, France., Collonge-Rame MA; Oncobiologie Génétique Bioinformatique, PCBio, CHU Besançon, Besançon, France., Populaire C; Oncobiologie Génétique Bioinformatique, PCBio, CHU Besançon, Besançon, France., Selmani Z; Oncobiologie Génétique Bioinformatique, PCBio, CHU Besançon, Besançon, France., Baurand A; Service d'Oncogénétique, Centre Georges François Leclerc, Dijon, France.; Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l'Interrégion Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France., Sawka C; Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l'Interrégion Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France., Bertolone G; Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l'Interrégion Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France., Callier P; Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.; Unité Fonctionnelle Innovation diagnostique dans les maladies rares, laboratoire de génétique chromosomique et moléculaire, Plateau Technique de Biologie, CHU Dijon Bourgogne, Dijon, France.; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France., Duffourd Y; Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France., Jonveaux P; Laboratoire de Génétique Médicale, INSERM U954, Hôpitaux de Brabois, Vandoeuvre les Nancy, France., Bignon YJ; Laboratoire d'Oncologie Moléculaire, Centre Jean Perrin, Clermont-Ferrand, France., Coupier I; Unité d'Oncogénétique, ICM Val d'Aurel, Montpellier, France., Cornelis F; Université Bordeaux, IMB, UMR 5251, Talence, France.; Service d'imagerie diagnostique et interventionnelle de l'adulte, Hôpital Pellegrin, CHU de Bordeaux, France., Cordier C; UF6948 oncogénétique, CHRU de Strasbourg, France., Mozelle-Nivoix M; Service de génétique, CHU-Reims, France., Rivière JB; Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.; Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l'Interrégion Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France.; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France., Kuentz P; Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.; Oncobiologie Génétique Bioinformatique, PCBio, CHU Besançon, Besançon, France.; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France., Thauvin C; Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.; Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l'Interrégion Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France., Boidot R; Département de biologie et pathologie des tumeurs, Centre Georges François Leclerc, Dijon, France., Ghiringhelli F; Département d'oncologie médicale, INSERM LNC U1231, Centre Georges François Leclerc, Dijon, France., O'Driscoll M; Human DNA Damage Response Disorders Group, University of Sussex, Genome Damage and Stability Centre, Brighton, United Kingdom., Faivre L; Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.; Service d'Oncogénétique, Centre Georges François Leclerc, Dijon, France.; Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l'Interrégion Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France.; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France., Nambot S; Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.; Service d'Oncogénétique, Centre Georges François Leclerc, Dijon, France.; Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l'Interrégion Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France.; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France.

Source: Oncotarget [Oncotarget] 2023 Feb 07; Vol. 14, pp. 111-125. Date of Electronic Publication: 2023 Feb 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/genetics, Female ; Humans ; Male ; Alleles ; Ataxia Telangiectasia Mutated Proteins/genetics ; Genetic Predisposition to Disease ; Phenotype ; Phosphorylation ; Breast Neoplasms, Male/genetics

Authors: Solla Negrao EM; Cancer Prevention Institute, Barretos Cancer Hospital, Campinas, Brazil., Cabello C; Obstetrics and Gynecology Department, University of Campinas, Campinas, Brazil., Conz L; Cancer Prevention Institute, Barretos Cancer Hospital, Campinas, Brazil.; Obstetrics and Gynecology Department, University of Campinas, Campinas, Brazil., Mauad EC; Cancer Prevention Institute, Barretos Cancer Hospital, Campinas, Brazil., Zeferino LC; Obstetrics and Gynecology Department, University of Campinas, Campinas, Brazil., Vale DB; Obstetrics and Gynecology Department, University of Campinas, Campinas, Brazil.

Source: Journal of medical screening [J Med Screen] 2023 Mar; Vol. 30 (1), pp. 42-46. Date of Electronic Publication: 2022 Sep 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 9433359 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1475-5793 (Electronic) Linking ISSN: 09691413 NLM ISO Abbreviation: J Med Screen Subsets: MEDLINE

Authors: Deng N; Department of Breast Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China., Zhang X; Department of Pathology, College of Basic Medical Sciences and First Affiliated Hospital, China Medical University, Shenyang, China., Zhang Y; Department of Pathology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.

Source: Cancer science [Cancer Sci] 2023 Mar; Vol. 114 (3), pp. 764-780. Date of Electronic Publication: 2022 Dec 01.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

Authors: Byrne HL; ACRF Image X Institute, School of Health Sciences, The University of Sydney, Sydney, Australia., Steiner E; LK Wiener Neustadt, Wiener Neustadt, Austria., Booth J; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia.; School of Physics, The University of Sydney, Sydney, Australia., Lamoury G; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Morgia M; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Richardson K; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Ambrose L; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Makhija K; ACRF Image X Institute, School of Health Sciences, The University of Sydney, Sydney, Australia., Stanton C; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Zwan B; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Bromley R; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Atyeo J; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Silvester S; ACRF Image X Institute, School of Health Sciences, The University of Sydney, Sydney, Australia., Plant N; ACRF Image X Institute, School of Health Sciences, The University of Sydney, Sydney, Australia., Keall P; ACRF Image X Institute, School of Health Sciences, The University of Sydney, Sydney, Australia. Paul.Keall@sydney.edu.au.

Source: Trials [Trials] 2023 Feb 22; Vol. 24 (1), pp. 132. Date of Electronic Publication: 2023 Feb 22.

Publication Type: Randomized Controlled Trial; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

Authors: Al-Keilani MS; College of Pharmacy, Department of Clinical Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, 22110, Irbid, Jordan. mskeilani@just.edu.jo., Bdeir R; College of Nursing, Department of Allied Health Sciences, Al-Balqa Applied University, Al-Salt 19117, P.O. Box 206, Salt, Jordan., Elstaty RI; College of Science and Art, Department of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, P.O. Box 3030, 22110, Irbid, Jordan., Alqudah MA; College of Medicine, Department of Microbiology, Pathology, and Forensic Medicine, The Hashemite University, P.O. Box 330127, 13133, Zarqa, Jordan.

Source: BMC cancer [BMC Cancer] 2023 Feb 16; Vol. 23 (1), pp. 158. Date of Electronic Publication: 2023 Feb 16.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Bouchmaa N; Faculty of Science and Technology, Team of Experimental Oncology and Natural Substances, Cellular and Molecular Immuno-Pharmacology, Sultan Moulay Slimane University, Beni-Mellal, Morocco.; Institute of Medical and Biological Sciences, Mohammed VI Polytechnic University (UM6P), Ben-Guerir, Morocco., Ben Mrid R; Institute of Medical and Biological Sciences, Mohammed VI Polytechnic University (UM6P), Ben-Guerir, Morocco.; Faculty of Science and Technology, Laboratory of Biochemistry and Molecular Genetics, Abdelmalek Essaadi University, Tangier, Morocco., Bouargalne Y; Faculty of Science and Technology, Laboratory of Biochemistry and Molecular Genetics, Abdelmalek Essaadi University, Tangier, Morocco., Ajouaoi S; Faculty of Science and Technology, Team of Experimental Oncology and Natural Substances, Cellular and Molecular Immuno-Pharmacology, Sultan Moulay Slimane University, Beni-Mellal, Morocco., Cacciola F; Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, Messina, Italy., El Fatimy R; Institute of Medical and Biological Sciences, Mohammed VI Polytechnic University (UM6P), Ben-Guerir, Morocco., Nhiri M; Faculty of Science and Technology, Laboratory of Biochemistry and Molecular Genetics, Abdelmalek Essaadi University, Tangier, Morocco., Zyad A; Faculty of Science and Technology, Team of Experimental Oncology and Natural Substances, Cellular and Molecular Immuno-Pharmacology, Sultan Moulay Slimane University, Beni-Mellal, Morocco.

Source: PloS one [PLoS One] 2023 Feb 09; Vol. 18 (2), pp. e0272781. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Delgado AB; Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway., Tylden ES; Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway., Lukic M; Department of Community Medicine, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway., Moi L; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway., Busund LR; Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway., Lund E; Department of Community Medicine, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway., Olsen KS; Department of Community Medicine, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway.

Source: PloS one [PLoS One] 2023 Feb 06; Vol. 18 (2), pp. e0281218. Date of Electronic Publication: 2023 Feb 06 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: He Y; Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Chen S; Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Gao X; Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Fu L; Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Kang Z; Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Liu J; Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Shi L; Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Li Y; Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China.

Source: PloS one [PLoS One] 2023 Jan 24; Vol. 18 (1), pp. e0280456. Date of Electronic Publication: 2023 Jan 24 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Liede A; AbbVie Inc, North Chicago, IL, USA. alex.liede@abbvie.com.; AbbVie Limited, Dublin, Ireland. alex.liede@abbvie.com.; Global Epidemiology, Pharmacovigilance & Patient Safety, AbbVie 14 Riverwalk, Citywest Business Campus, NSW, D24 XN32, Dublin, Ireland. alex.liede@abbvie.com., Sebby W; AbbVie Inc, North Chicago, IL, USA., Miriyala AKR; AbbVie Inc, North Chicago, IL, USA., Potluri R; SmartAnalyst Inc, New York, NY, USA., Mazumder D; SmartAnalyst India Pvt. Ltd, Gurugram, India., Ghosh A; SmartAnalyst India Pvt. Ltd, Gurugram, India., Papademetriou E; SmartAnalyst Inc, New York, NY, USA., Kilpatrick R; AbbVie Inc, North Chicago, IL, USA., Tyczynski JE; National Institute of Oncology, Warsaw, Poland.

Source: BMC cancer [BMC Cancer] 2023 Jan 24; Vol. 23 (1), pp. 78. Date of Electronic Publication: 2023 Jan 24.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Flood E; AstraZeneca plc, Patient-Centered Science, Gaithersburg, Maryland, United States of America., Krasnow A; IQVIA Real World Solutions, Patient-Centered Solutions, London, United Kingdom., Orbegoso C; AstraZeneca plc, R&D Oncology, Cambridge, United Kingdom., Karantzoulis S; IQVIA Real World Solutions, Patient-Centered Solutions, New York, New York, United States of America., Bailey J; IQVIA Real World Solutions, Patient-Centered Solutions, New York, New York, United States of America., Bayet S; IQVIA Real World Solutions, Patient-Centered Solutions, Courbevoie, France., Elghouayel A; IQVIA Real World Solutions, Patient-Centered Solutions, New York, New York, United States of America., Foxley A; AstraZeneca plc, R&D Oncology, Cambridge, United Kingdom., Sommavilla R; AstraZeneca plc, R&D Oncology, Cambridge, United Kingdom., Schiavon G; AstraZeneca plc, R&D Oncology, Cambridge, United Kingdom.

Source: PloS one [PLoS One] 2023 Jan 17; Vol. 18 (1), pp. e0280259. Date of Electronic Publication: 2023 Jan 17 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Verbeek JGE; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., de Jong VMT; Department of Molecular Pathology, Antoni Van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands., Wijnja HM; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Linn SC; Department of Molecular Pathology, Antoni Van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Antoni Van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Utrecht University Medical Centre, Utrecht, The Netherlands., Retèl VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands. v.retel@nki.nl.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands. v.retel@nki.nl., van Harten WH; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.

Source: BMC cancer [BMC Cancer] 2023 Jan 07; Vol. 23 (1), pp. 26. Date of Electronic Publication: 2023 Jan 07.

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Kim J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea., Jeong K; Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea.; Transdisciplinary Department of Medicine and Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea., Jun H; Transdisciplinary Department of Medicine and Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea., Kim K; Transdisciplinary Department of Medicine and Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea., Bae JM; Department of Pathology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Song MG; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea., Yi H; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea., Park S; Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Woo GU; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea., Lee DW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea., Kim TY; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea., Lee KH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. kyunghunlee@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. kyunghunlee@snu.ac.kr., Im SA; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. moisa@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. moisa@snu.ac.kr.

Source: Human genomics [Hum Genomics] 2023 Jan 06; Vol. 17 (1), pp. 2. Date of Electronic Publication: 2023 Jan 06.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101202210 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-7364 (Electronic) Linking ISSN: 14739542 NLM ISO Abbreviation: Hum Genomics Subsets: MEDLINE

Authors: Liu S; Department of Radiology, The First Hospital of China Medical University, Shenyang, 110001, China., Du S; Department of Radiology, The First Hospital of China Medical University, Shenyang, 110001, China., Gao S; Department of Radiology, The First Hospital of China Medical University, Shenyang, 110001, China., Teng Y; Departments of Medical Oncology and Thoracic Surgery, The First Hospital of China Medical University, Shenyang, 110001, China., Jin F; Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, 110001, China. jinfeng@cmu.edu.cn., Zhang L; Department of Radiology, The First Hospital of China Medical University, Shenyang, 110001, China. zhanglnda@163.com.

Source: BMC cancer [BMC Cancer] 2023 Jan 05; Vol. 23 (1), pp. 15. Date of Electronic Publication: 2023 Jan 05.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Goto W; Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan., Kashiwagi S; Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan. spqv9ke9@view.ocn.ne.jp., Takada K; Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan., Asano Y; Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan., Ogisawa K; Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan., Morisaki T; Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan., Shibutani M; Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan., Tanaka H; Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan., Maeda K; Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.

Source: European journal of medical research [Eur J Med Res] 2023 Jan 02; Vol. 28 (1), pp. 2. Date of Electronic Publication: 2023 Jan 02.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 9517857 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-783X (Electronic) Linking ISSN: 09492321 NLM ISO Abbreviation: Eur J Med Res Subsets: MEDLINE

Authors: Belhechmi S; Université Paris-Saclay, CESP, INSERM U1018 Oncostat, labeled Ligue Contre le Cancer, Villejuif, France.; Bureau de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France., Le Teuff G; Université Paris-Saclay, CESP, INSERM U1018 Oncostat, labeled Ligue Contre le Cancer, Villejuif, France.; Bureau de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France., De Bin R; Department of Mathematics, University of Oslo, Oslo, Norway., Rotolo F; Biostatistics and Data Management Unit, Innate Pharma, Marseille, France., Michiels S; Université Paris-Saclay, CESP, INSERM U1018 Oncostat, labeled Ligue Contre le Cancer, Villejuif, France. Stefan.MICHIELS@gustaveroussy.fr.; Bureau de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France. Stefan.MICHIELS@gustaveroussy.fr.

Source: BMC bioinformatics [BMC Bioinformatics] 2023 Mar 16; Vol. 24 (1), pp. 96. Date of Electronic Publication: 2023 Mar 16.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100965194 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2105 (Electronic) Linking ISSN: 14712105 NLM ISO Abbreviation: BMC Bioinformatics Subsets: MEDLINE

Authors: Almeshari M; Department of Diagnostic Radiology, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia., Alzamil Y; Department of Diagnostic Radiology, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia., Alyahyawi A; Department of Diagnostic Radiology, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia.; Centre for Nuclear and Radiation Physics, Department of Physics, University of Surrey, Guildford, Surrey, United Kingdom., Abanomy A; Department of Radiological Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia., Althmali O; Department of Physiotherapy, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia., Al-Enezi MS; Department of Diagnostic Radiology, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia., C G S; Department of Physiotherapy, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia., Osman H; Department of Radiological Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia., Khandaker MU; Centre for Applied Physics and Radiation Technologies, School of Engineering and Technology, Sunway University, Bandar Sunway, Kuala Lumpur, Selangor, Malaysia.; Department of General Educational Development, Faculty of Science and Information Technology, Daffodil International University, Dhaka, Bangladesh.

Source: PloS one [PLoS One] 2023 Mar 15; Vol. 18 (3), pp. e0282916. Date of Electronic Publication: 2023 Mar 15 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Milambo JPM; Department of Health Sciences, Division of Public Health, University of Free state, 205 Nelson Mandela Dr, Bloenfontein , 9301, South Africa. jeanpaulmilambo2@gmail.com., Nyasulu PS; Department of Global Health, Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa., Akudugu JM; Division of Radiobiology, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa., Ndirangu J; Department of Health Sciences, Division of Public Health, University of Free State, Bloenfontein , South Africa.

Source: BMC research notes [BMC Res Notes] 2023 Mar 13; Vol. 16 (1), pp. 37. Date of Electronic Publication: 2023 Mar 13.

Publication Type: Observational Study; Journal Article

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500 (Electronic) Linking ISSN: 17560500 NLM ISO Abbreviation: BMC Res Notes Subsets: MEDLINE